Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Prologue Research International
- Study ID
- NCT00062426
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- bevacizumab — BIOLOGICAL
- capecitabine — DRUG
- fluorouracil — DRUG
- leucovorin calcium — DRUG
- oxaliplatin — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, fluorouracil, leucovorin, and capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving them in different combinations may kill more tumor cells. Monoclonal antibodies, such as bevacizumab (Avastin™), can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or deliver cancer-killing substances to them. It is not yet known which regimen works better in treating advanced colorectal cancer. PURPOSE: This randomized phase III trial is to see if oxaliplatin and bevacizumab work better when combined with either fluorouracil and leucovorin or capecitabine in treating patients who have metastatic or recurrent colorectal cancer.
Key Dates
- First listed
- Jun 6, 2003
- Start date
- May 31, 2003
- Status verified
- Apr 2004
- Completion
- Feb 28, 2011
Study Design
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Locations (52)
Find similar trials in Birmingham, AL
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer PatientsRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruiting · University of Missouri-Columbia · Columbia, Missouri